Volume 16, Number 5—May 2010
Bluetongue Virus in Wild Deer, Belgium, 2005–2008
Highlight and copy the desired format.
|EID||Linden A, Grégoire F, Nahayo A, Hanrez D, Mousset B, Massart AL, et al. Bluetongue Virus in Wild Deer, Belgium, 2005–2008. Emerg Infect Dis. 2010;16(5):833-836. https://dx.doi.org/10.3201/eid1605.091217|
|AMA||Linden A, Grégoire F, Nahayo A, et al. Bluetongue Virus in Wild Deer, Belgium, 2005–2008. Emerging Infectious Diseases. 2010;16(5):833-836. doi:10.3201/eid1605.091217.|
|APA||Linden, A., Grégoire, F., Nahayo, A., Hanrez, D., Mousset, B., Massart, A. L....De Clercq, K. (2010). Bluetongue Virus in Wild Deer, Belgium, 2005–2008. Emerging Infectious Diseases, 16(5), 833-836. https://dx.doi.org/10.3201/eid1605.091217.|
To investigate bluetongue virus serotype 8 infection in Belgium, we conducted a virologic and serologic survey on 2,416 free-ranging cervids during 2005–2008. Infection emerged in 2006 and spread over the study area in red deer, but not in roe deer.
Bluetongue virus serotype 8 (BTV-8) spread throughout western Europe in 2006. Belgium reported its first case in farm ruminants in 2006. Because some cervid species may be seriously affected by BTV and because they may be reservoir hosts (1), we conducted a large-scale survey of BTV-8 in Belgium.
Postmortem examinations were conducted on 1,620 red deer and 796 roe deer shot by hunters during hunting seasons in 2005–2008 (Technical Appendix [PDF - 65 KB - 1 page]). Sex, age, body condition, and macroscopic aspects of hooves, mucosae, and internal organs were recorded. Blood and spleen samples were obtained.
Antibodies against virus protein 7 were detected by using a competition ELISA kit (ID-VET, Montpellier, France). Results were expressed as percentage negativity compared with kit negative control serum, and cutoff values were established. Serum samples from 80 red deer and 40 roe deer were also analyzed by using a virus neutralization (VN) test for BTV-1 and BTV-8. Spleen samples obtained in 2006 and 2007 were used for detection of BTV RNA segment 5 and cellular β-actin transcripts by reverse transcription–quantitative PCR (RT-qPCR) according to a modified procedure of Toussaint et al. (2).
To assess performance of the ELISA, we performed receiver operating characteristic analysis. To estimate effects of potential factors (sex and age, year, month and area of sampling) on risk for seropositivity, we used a multivariate logistic regression model. Between-group differences were assessed by using the χ2 test.
A total of 237 pairs of ELISA and RT-qPCR results from red deer were used for receiver operating characteristic analysis, which yielded an area under the curve of 0.811 and a cutoff value for the ELISA that maximized sensitivity (86%) and specificity (98%). Serologic status was defined as positive (<66%), doubtful (>66%–<75%), or negative (>75%) and was comparable to that found for domestic ruminants (3). For BTV-8, concordance between ELISA and VN results was 95% for red deer and 82% for roe deer. Neutralizing antibodies to BTV-1 were not detected.
From 2006 on, no gross lesions compatible with bluetongue disease were found. In 2005, all serum samples were negative. For hunting seasons in 2006, 2007, and 2008, seroprevalences were 1.51% (95% confidence interval [CI] 0.89%–2.07%), 52.33% (95% CI 49.91%–54.78%), and 33.95% (95% CI 31.64%–36.26%) for red deer and 2.56% (95% CI 1.43%–3.60%), 2.75% (95% CI 1.62%–3.90%), and 1.67% (95% CI 0.75%–2.51%) for roe deer and showed a significant difference between species (p<0.0001 by Cochran-Mantel test).
Yearly profiles of humoral immune responses are shown in Figure 1. Unimodal negatively skewed distributions of percentage negativity in 2005 and 2006 likely reflect seronegative populations. Conversely, bimodal profiles in 2007 and 2008 are compatible with ongoing infections in the red deer population. Spatial evolution of humoral responses in red deer is shown in Figure 2. In 2006, seropositive animals were detected in only 5 districts, of which 4 were the most eastern districts among the 20 sampled; deer in most districts were infected in 2007 (22/25) and 2008 (17/21).
In red deer, multiple logistic regression analysis showed that risk for seropositivity was significantly affected by age (χ2 84.53, p<0.0001), year (χ2 282.75, p<0.0001), and location of sampling (χ2 63.10, p<0.0001), but not by sex (χ2 0.19, p>0.90) or month of sampling (χ2 2.45, p>0.45). Seroprevalence was lower for juveniles than for subadults (odds ratio 2.11, 95% CI 1.47–3.04) and adults (odds ratio 3.79, 95% CI 2.85–4.62). The decrease in 2008 was significant only for juveniles, and the seropositivity gradient decreased toward southern part of the study region (Table). For roe deer, risk for seropositivity was not influenced by any factor.
The 343 spleen samples (230 red deer and 113 roe deer) tested by RT-qPCR in 2006 and the 193 samples (roe deer) tested in 2007 were negative for BTV RNA. Conversely, ≈14% (33/237) of red deer β-actin–positive samples (237/331) were positive for BTV RNA (Technical Appendix [PDF - 65 KB - 1 page]). These 33 animals did not have gross lesions suggestive of bluetongue disease. Of 32 serum samples available, 26 were seropositive, 1 was doubtful, and 5 were seronegative, which suggested that these animals had been infected recently. Two pan-BTV RNA–positive spleen fragments, sampled at the end of hunting season in 2008, were reassessed by using a BTV-8 genotype–specific RT-qPCR (4); results were positive for all.
Our study provides evidence that BTV-8 infects wild cervid populations in Belgium. For red deer, a few infections occurred in 2006 in the eastern part of Belgium, i.e., the area in which the ovine and bovine cases had been detected (5). In 2007, the infection spread west and southwest, and its seroprevalence increased. In 2008, distribution remained stable but overall seroprevalence decreased, mostly among juveniles. Distribution profiles of antibodies against BTV in 2007 and 2008 showed a bimodal profile. A large number of serum samples showed percentage negativity values between positive and negative values, which is indicative of ongoing virus transmission by vector midges during the hunting season. More animals were infected in eastern and central than in southern Wallonia, a finding that resembles the spatial distribution of the virus in livestock and might be correlated with lower density of cattle populations and cooler temperatures in hilly southern districts (6).
The proportion of seropositive animals increased with age, probably resulting more from prolonged exposure of adults to the vector, than to any resistant status of juveniles. Decreasing overall seroprevalence in 2008 might be caused by mandatory vaccination of domestic ruminants and spontaneously acquired herd immunity within the red deer population, which reduced virus prevalence among insect vector populations in 2008. Because seropositive subadults and adults sampled in 2008 could have been infected in 2007, seroprevalence among juveniles should more accurately reflect the level of exposure to infected insect vectors. If this explanation was true, the decrease in seroprevalence among juveniles in 2008 would confirm reduction of the virus insect reservoir.
Although red deer and roe deer samples were collected at the same locations and during the same hunting events, seroprevalence was lower among roe deer. Because 5 of 12 ELISA-positive and none of the ELISA-negative roe deer serum samples were positive by BTV-8 VN test and a similar between-species pattern was found by RT-qPCR, poor sensitivity of the ELISA in roe deer as the cause of between-species difference can be ruled out. Host-related and vector-related factors might account for this difference. Because red deer live in large groups and move more, they might be more exposed to insects/pathogens than are roe deer, which live in small groups in winter and have smaller home-range sizes and are seasonally territorial (7). Moreover, a recent follow-up of Culicoides spp. midge feeding patterns reported variations in host attractiveness, which could correlate with exhaled carbon dioxide and acetone (8), specific phenolic compounds emitted from urine (9) or hair fragrance (10).
BTV might be maintained in an as yet unknown reservoir host population with a long or relapsing viremia and in which clinical signs are absent. Because no excess illness or death occurred in 2007–2008, BTV-8 infection of wild cervids is probably benign enough to go unnoticed. Some spleen samples from dead red deer found during winter also showed positive results by RT-qPCR even if BTV was not the cause of death (A. Linden, unpub. data). Coupled with the high seroprevalence we report, the possibility that red deer are BTV reservoirs warrants further investigation.
Dr Linden is a professor in the Department of Infectious and Parasitic Diseases in the Veterinary Faculty of the University of Liège. Her research interests focus on wildlife diseases.
We thank the forest rangers; scientific collaborators from the Département Nature et Forêts, Public Service of Wallonia; military personnel; and hunters for assistance with field work.
This study was supported by a regional grant from the Public Service of Wallonia.
- Wilson A, Darpel K, Mellor PS. Where does bluetongue virus sleep in the winter? PLoS Biol. 2008;6:e210.
- Toussaint JF, Sailleau C, Breard E, Zientara S, De Clercq K. Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments. J Virol Methods. 2007;140:115–23.
- Vandenbussche F, Vanbinst T, Verheyden B, Van Dessel W, Demeestere L, Houdart P, Evaluation of antibody-ELISA and real-time RT-PCR for the diagnosis and profiling of bluetongue virus serotype 8 during the epidemic in Belgium in 2006. Vet Microbiol. 2008;129:15–27.
- Vandenbussche F, De Leeuw I, Vandemeulebroucke E, De Clercq KB. Emergence of bluetongue serotypes in Europe, part 1: description and validation of four real-time RT-PCR assays for the genotyping of bluetongue viruses BTV-1, BTV-6, BTV-8 and BTV-11. Transbound Emerg Dis. 2009;56:346–54.
- Toussaint JF, Sailleau C, Mast J, Houdart P, Czaplicki G, Demeestere L, Bluetongue in Belgium, 2006. Emerg Infect Dis. 2007;13:614–6.
- Meroc E, Faes C, Herr C, Staubach C, Verheyden B, Vanbinst T, Establishing the spread of bluetongue virus at the end of the 2006 epidemic in Belgium. Vet Microbiol. 2008;131:133–44.
- Hewison AJM, Vincent JP, Reby D. Social organisation of European roe deer. In: Andersen R, Duncanb P, Linnell JD, editors. The European roe deer: the biology of success. Oslo (Norway): Scandinavian University Press; 1998. p. 189–221.
- Bartsch S, Bauer B, Wiemann A, Clausen PH, Steuber S. Feeding patterns of biting midges of the Culicoides obsoletus and Culicoides pulicaris groups on selected farms in Brandenburg, Germany. Parasitol Res. 2009;105:373–80.
- Bhasin A, Mordue Luntz AJ, Mordue W. Field studies on efficacy of host odour baits for the biting midge Culicoides impunctatus in Scotland. Med Vet Entomol. 2001;15:147–56.
- Mands V, Kline DL, Blackwell A. Culicoides midge trap enhancement with animal odour baits in Scotland. Med Vet Entomol. 2004;18:336–42.
- Figure 1. Frequency distribution of results of a competitive ELISA for detecting antibodies against bluetongue virus in serum samples from roe deer (white columns) and red deer (black columns) during the...
- Figure 2. Distribution of red deer samples obtained in Belgium (Wallonia) in A) 2005, B) 2006, C) 2007, and D) 2008, and location of forest districts. White circles indicate districts where...
Technical AppendixCite This Article
Please use the form below to submit correspondence to the authors or contact them at the following address:
Annick Linden, Surveillance Network of Wildlife Diseases, Department of Infectious and Parasitic Diseases, University of Liège, FMV Sart Tilman, B43, Liège 4000, Belgium
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 23, 2010
- Page last updated: December 23, 2010
- Page last reviewed: December 23, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)